There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45 th Annual Health ...

Moderna, Inc. engages in the development of ... Chien in 2010 and is headquartered in Cambridge, MA.

Following four straight sessions of gains, Moderna (NASDAQ ... 17 European countries will have access to the Cambridge, MA-based biotech's messenger RNA-based shot for up to four years.

Cambridge, Mass.-based Moderna MRNA had a net loss of $1.1 billion for the quarter, or $2.91 a share, after earnings of $217 million, or 55 cents a share, in the year-earlier period. Back To Top ...